News FDA delays decision on abuse deterrence data on Endo painkil... Data could be used to fend off generic competition.
News Branded pharma condemns UK generic price hiking Newspaper investigation reveals small number of companies hiking the prices of generic drugs.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.